Антифосфолипидный синдром - Насонов Е.Л.
ISBN 5-98216-010-5
Скачать (прямая ссылка):
255. Erkan D, Bateman H, Lockshin MD. Lupus anticoagulant-hypoprothrombinemia syndrome associated with systemic lupus erythemato-sus: report of 2 cases and review of literature. Lupus 1999; 8: 560.
256. McNeil HP, Chesterman CN, Krilis SA. Immunology and clinical importance of anti-phospholipid antibodies. Adv Immunol 1991; 49:193.
257. Harris EN, Gharavi AE, Hegde U, et al. Anticardiolipin antibodies in autoimmune throm-bocytopenic purpura. Br J Haematol 1985; 59: 231.
258. Diz-Kucukkaya R, Hacihanefioglu A, Yenerel M, et al. Antiphospholipid antibodies and antiphospholipd syndrome in patients presenting with immune thrombocytopenic purpura: A prospective cohort study. Blood 2001; 98: 1760.
259. Lee T, von Scheven E, Sandborg C. Systemic lupus erythematosus and antiphospholipid syndrome in children and adolescent. Curr Opin Rheumatol 2001; 13: 415—421.
260. Насонов ЕЛ, Рябова ТВ, ПІпитонкова ОЛ, Александрова ЕН. Антифосфолипидный синдром в педиатрии. Детская ревматология 1995; 1: 67—73.
261. Ravelli A, Caporali R, Di Fuccia G, et al. Anticardiolipin antibodies in pediatric systemic lupus erythematosus. Arch Pediatr Adolesc Med 1994; 148: 398—402.
262. Seaman DE, Londjino AV, Jr, Kwoh CK, et al. Antiphospholipid antibodies in pediatric systemic lupus erythematosus. Pediatrics 1995; 96: 1040—1045.
263. Gattorno M, Buoncompagni A, Molinari AC, et al. Antiphospholipid antibodies in paedi-atric systemic lupus eruthematosus, juvenile chronic arthritis and overlap syndromes: SLE patients wuth both lupus anticoagulant and high-titre anicardiolipin antibodies are at risk for clinical manifestations related to the antiphospholipid syndrome. Br J Rheumatol 1995; 34: 873—881.
SHS-OOO4.qxd 21.11.2006 16:56 Page 2p6-
Насонов Е.Л. Антифосфолипидный синдром.
264. Shergy WJ, Kredich DW, Pisetsky DS. The relationship of anticardiolipin antibodies to disease manifwestations in pediatric systemic lupus erythematosus. J Rheumatol 1988; 15: 1389—1394.
265. Berube C, Mitchell L, Silverman E, et al. The relationship of anticardiolipin antibodies to thromboembolic events in pediatriv patients with systemic lupus erythematosus: a cross-sectional study. Pediatr Res 1998; 44: 351—358.
266. von Scheven EY, Glidden DV, Elder ME. Anti-?2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospho-lipid syndrome Arthritis Rheum (Arthritis Care Res) 2002; 47: 414—420.
267. Falcini F, Tacetti G, Trapani S, et al. Primary antiphospholipid syndromeL a report of two pediatric cases. J Rheumatology 1991; 18: 1085—1087.
268. Von Landenberg P, Lehmann HW, Knoll A, et al. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection. Arthritis Rheum 2003; 48: 1939—1947.
269. Shpitonkova OV, Ryabova TV, Alexan-drova EN, Nasonov EL. Antiphospholipid syndrome (APS) in children with SLE. III European Conference on Systemic Lupus Erythematosus, 1996, Pisa, Italy, 47 (126 abst).
270. Chang D-M, Chang C-C, Kuo S-Y, Chu S-J, Chang M-L. Hormonal profiles and immunological studies of male lupus in Taiwan. Clin Rheum 1999; 18: 158—162.
271. Folomeev M, Afanasjev W, Alekberova Z. Survival prognostic factors revealed from initial features of systemic lupus erythematosus in male patients. III Intern. Conference on SLE, London, Lupus 1992; 1 (Suppl 1): 122 (аbst).
272. Masi AT, Kaslow RA. Sex effects in systemic lupus erythematosus: a clue to pathogenesis. Arthr Rheum 1978; 21: 480—484.
273. Kaufman LD, Gomez-Reino JJ, Heinicke MH, Gorevic P.D. Male lupus: retrospective analysis of the clinical and laboratory features of 52 patients, with review of the literature. Sem Arthr Rheum 1989; 18, 3, 189— 197.
274. Koh WH, Fong KY, Boey ML, Feng PH. Systemic lupus etythematosus in 61 orien-
tal males. A study of clinical and laboratory manifestations. Br J Rheum 1994; 33, 339— 342.
275. Miller MH, Urowitz MB, Gladman D.D., Killinger D.W. Systemic lupus erythematosus in males. Medicine (Baltimore) 1983; 62, 5, 327— 334.
276. Sthoeger ZM, Geltner D, Rider A, Bent-wich Z. Systemic lupus erythematosus in 49 Israel males: a retrospective study. Clin Exp Rheum 1987; 5: 233—240.
277. Alarcon-Segovia D. Antiphospholipid syndrome in SLE. Lupus 1992; 1, (Suppl 1): 13 (abst).
278. Насонов ЕЛ, Алекберова ЗС, Клюквина НГ, Александрова ЕН, Саложин КВ, Ле Тон-гез М, Юну П. Антифосфолипидный синдром при системной красной волчанке у мужчин. Клин. медицина, 1996; 4: 18—22.
279. Asherson RA. The "primary" antiphospho-lipid syndrome. J Rheumatol 1988; 15: 742— 1746.
280. Alarcon-Segovia D, Sanchez-Guerrero J. Primary antiphospholipid syndrome J Rheumatol 1989; 16: 482—488.
281. Mackworth-Young CG, Loizou S, Walport MJ. Primary antiphospholipid syndrome: features with raised anticardiolipin antibodies and other disorders. Ann Rheum Dis 1989; 48: 362—367.
282. Mujic F, Cuadrado MJ, Lloyd M, et al. Primary antiphospholipid antibody syndrome evolving into systemic lupus erythematosus. J Rheumatol 1995; 22: 1589.
